Why BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
The company isn't giving up on a promising pipeline drug.
Brainstorm Cell Therapeutics Inc.
The company isn't giving up on a promising pipeline drug.
The company reported disappointing results from a pivotal clinical trial.